Announcement on Pentazocine Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs

Announcement on Drugs of Wholly-owned Subsidiary Passing the Generics Consistency evalsuation

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2024

Change of Branch Share Registrar and Transfer Office in Hong Kong

Announcement on Absorption and Merger of Wholly-owned Subsidiary

Renewal of Continuing Connected Transactions and Related Party Transaction and Entering into of Continuing Connected Transactions

Overseas Regulatory Announcement-Announcement on Having Obtained FDA approval of Abbreviated New Drug Application (ANDA)

Overseas regulatory announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Articles of Association

Poll Results of The Extraordinary General Meeting